Simbo
Simbo, licence 80000446: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nutragenius Inc.
- NPN or DIN-HM
- 80000446
- Status
- Inactive licence
- Licence date
- 7 June 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Acts as a source of amino acid for maintenance of heart health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have human herpes virus. Consult a health care practitioner prior to use if you have sickle cell anemia. Consult a health care practitioner prior to use if you are taking antihypertensives, cyclosporine, estrogens, birth control medications, medroxyprogesterone, norethindrone, nitrates, potassium-increasing drugs, sildenafil, xylitol, and/or aminphyllins. Discontinue use if you have gout. Discontinue use if you have decreased platelet count. Discontinue use if you have elevated blood-urea-nitrogen, serum creatine and cretinine. Discontinue use if you have delayed menses.
Source
Official Health Canada record, licence 80000446
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.